21 CFR Part 341, Subpart C - Labeling
prev | next
- § 341.70 — Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product).
- § 341.72 — Labeling of antihistamine drug products.
- § 341.74 — Labeling of antitussive drug products.
- § 341.76 — Labeling of bronchodilator drug products.
- § 341.78 — Labeling of expectorant drug products.
- § 341.80 — Labeling of nasal decongestant drug products.
- § 341.85 — Labeling of permitted combinations of active ingredients.
- § 341.90 — Professional labeling.
Title 21 published on 2015-04-01.
No entries appear in the Federal Register after this date, for 21 CFR Part 341.